a 71623 has been researched along with vasoactive intestinal peptide in 1 studies
| Studies (a 71623) | Trials (a 71623) | Recent Studies (post-2010) (a 71623) | Studies (vasoactive intestinal peptide) | Trials (vasoactive intestinal peptide) | Recent Studies (post-2010) (vasoactive intestinal peptide) |
|---|---|---|---|---|---|
| 27 | 0 | 2 | 10,873 | 123 | 1,221 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giralt, M; Vergara, P | 1 |
1 other study(ies) available for a 71623 and vasoactive intestinal peptide
| Article | Year |
|---|---|
Inhibition by CCK of ascending contraction elicited by mucosal stimulation in the duodenum of the rat.
Topics: Adrenergic beta-Antagonists; Animals; Atropine; Benzodiazepinones; Cholecystokinin; Depression, Chemical; Devazepide; Duodenum; Electric Stimulation; Enteric Nervous System; Enzyme Inhibitors; Gastrins; Hexamethonium; Intestinal Mucosa; Male; Muscle Contraction; Nicotinic Antagonists; Nitroarginine; Oligopeptides; Parasympatholytics; Peristalsis; Phentolamine; Phenylurea Compounds; Propranolol; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Receptors, Vasoactive Intestinal Peptide; Sincalide; Tetragastrin; Vasoactive Intestinal Peptide | 2000 |